Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
49.5M
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
44M
-
Shares change
-
+1.5M
-
Total reported value, excl. options
-
$2.45B
-
Value change
-
+$92.8M
-
Put/Call ratio
-
0.19
-
Number of buys
-
98
-
Number of sells
-
-75
-
Price
-
$55.67
Significant Holders of AtriCure, Inc. - Common Shares (ATRC) as of Q4 2020
219 filings reported holding ATRC - AtriCure, Inc. - Common Shares as of Q4 2020.
AtriCure, Inc. - Common Shares (ATRC) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44M shares
of 49.5M outstanding shares and own 88.96% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.76M shares), FRED ALGER MANAGEMENT, LLC (2.86M shares), VANGUARD GROUP INC (2.42M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.33M shares), Invesco Ltd. (2.25M shares), Champlain Investment Partners, LLC (2.14M shares), FMR LLC (1.9M shares), TimesSquare Capital Management, LLC (1.41M shares), ORBIMED ADVISORS LLC (1.23M shares), and CREDIT SUISSE AG/ (1.06M shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.